Dihydroartemisinin Triggers Ferroptosis in Multidrug-Resistant Leukemia Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dihydroartemisinin Triggers Ferroptosis in Multidrug-Resistant Leukemia Cells

Published:2022-08-01 Issue:8 Volume:41 Page:705-715
ISSN:1044-5498
Container-title:DNA and Cell Biology
language:en
Short-container-title:DNA and Cell Biology

Author:

Zhang Xueyan¹²^ORCID,Ai Ziying²,Zhang Zhewen²,Dong Rui²,Wang Lina²,Jin Suya²,Wei Hulai²

Affiliation:

1. Institute of Biochemistry and Molecular Biology and School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China.

2. Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/dna.2021.1145

Reference36 articles.

1. Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer

2. Broadening horizons: the role of ferroptosis in cancer

3. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells

4. Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism

5. Dihydroartemisinin: A Potential Natural Anticancer Drug

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the sulfur-containing amino acid pathway in leukemia;Amino Acids;2024-07-26

2. Natural products targeting ferroptosis pathways in cancer therapy (Review);Oncology Reports;2024-07-23

3. Targeting Metabolic–Redox Nexus to Regulate Drug Resistance: From Mechanism to Tumor Therapy;Antioxidants;2024-07-10

4. Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis;Scientific Reports;2024-05-10

5. Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy;Biomedicine & Pharmacotherapy;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3